Ask AI
ProCE Banner Activity

Real-world Effectiveness of Lenacapavir + Optimized Background Regimen in Heavily Treatment–Experienced People Living With HIV

Conference Coverage
Slideset

In this retrospective, real-world analysis in the United States, adding lenacapavir to optimized background antiretroviral therapy was highly efficacious and safe in heavily treatment–experienced people living with HIV and extensive resistance, comorbidities, and polypharmacy at 18 months.

Released: March 04, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions